Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$308K Hold
6,390
0.29% 136
2025
Q4
$310K Sell
6,390
-3,610
-36% -$179K 0.29% 148
2025
Q3
$472K Hold
10,000
0.35% 101
2025
Q2
$483K Hold
10,000
0.28% 128
2025
Q1
$555K Buy
+10,000
New +$541K 0.39% 86

Other funds holding SNY

Corient IA's SNY Position: Q1 2026 in Review

Corient IA held its Sanofi (SNY) position steady in Q1 2026 at 6,390 shares worth $308K. The position accounts for 0.29% of the portfolio, ranked #136.

Corient IA first reported a position in SNY in Q1 2025 and has held it in 5 quarters since. The position peaked at $555K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Corient IA held 6,390 shares of Sanofi worth $308K as of Q1 2026.
  • Corient IA left its Sanofi share count unchanged in Q1 2026.
  • Sanofi made up 0.29% of Corient IA's portfolio in Q1 2026, its #136 holding.
  • Corient IA first reported a position in Sanofi in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Sanofi position peaked at $555K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.